Heightened interest in infection prevention should be of benefit to Nanosonics in the wake of the pandemic, although rising cases in the short term create risks.
Preparing for the “green recovery” and social stimulus, ESG investors are focusing on the effects of covid-19 on individual environmental, social and governance themes, and lining up their ducks – FNArena summarises the winners and losers and checks out the post-covid geopolitical and anti-trust environments
McPherson’s has expanded into the herbal product segment by acquiring Global Therapeutics and can now build out that business across its pharmacy distribution channel.
Brambles has a defensive business with a dominant global position and is now more confident in the FY21 outlook.
The Chartist suggests WTI crude may be in for a bit more upside but warns only short term traders should take the risk.
A glance through the latest expert views and predictions about commodities. Coal; chemicals; steel; oil; and aluminium.
Ansell’s products are readily tailored to the waves of coronavirus sweeping the world so it is no surprise guidance for FY21 has already been upgraded.
Peter Switzer of the Switzer Report notes his ZEET tech play has copped a beating following the US tech sell-off but he is undeterred.
Michael Gable of Fairmont Equities notes Afterpay has pulled back toward its August peak and could be building upside once more.
Western Areas has downgraded guidance amid lower grades as its Forrestania mines come to the end of their lives. Hence, the future lies with Odysseus.
